Histone deacetylase 8 (HDAC8) and its inhibitors with selectivity to other isoforms: An overview

被引:88
|
作者
Banerjee, Suvankar [1 ]
Adhikari, Nilanjan [1 ,2 ]
Amin, Sk Abdul [1 ]
Jha, Tarun [1 ]
机构
[1] Jadavpur Univ, Dept Pharmaceut Technol, Nat Sci Lab, Div Med & Pharmaceut Chem, POB 17020, Kolkata 700032, W Bengal, India
[2] ADAMAS Univ, Sch Pharmaceut Technol, Barasat Barrackpore Rd,PO Jagannathpur, Kolkata 700126, W Bengal, India
关键词
Histone deacetylase; HDAC8; Cancer; inhibitor; Structure-activity relationship (SAR); Quantitative structure-activity relationship (QSAR); DE-LANGE-SYNDROME; SUBEROYLANILIDE HYDROXAMIC ACID; ZINC-BINDING GROUP; BIOLOGICAL EVALUATION; PHASE-I; MOLECULAR-MECHANISMS; CRYSTAL-STRUCTURE; ACTIVITY ASSAY; UP-REGULATION; DESIGN;
D O I
10.1016/j.ejmech.2018.12.039
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The histone deacetylases (HDACs) enzymes provided crucial role in transcriptional regulation of cells through deacetylation of nuclear histone proteins. Discoveries related to the HDAC8 enzyme activity signified the importance of HDAC8 isoform in cell proliferation, tumorigenesis, cancer, neuronal disorders, parasitic/viral infections and other epigenetic regulations. The pan-HDAC inhibitors can confront these conditions but have chances to affect epigenetic functions of other HDAC isoforms. Designing of selective HDAC8 inhibitors is a key feature to combat the pathophysiological and diseased conditions involving the HDAC8 activity. This review is concerned about the structural and positional aspects of HDAC8 in the HDAC family. It also covers the contributions of HDAC8 in the pathophysiological conditions, a preliminary discussion about the recent scenario of HDAC8 inhibitors. This review might help to deliver the structural, functional and computational information in order to identify and design potent and selective HDAC8 inhibitors for target specific treatment of diseases involving HDAC8 enzymatic activity. (C) 2018 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:214 / 240
页数:27
相关论文
共 50 条
  • [1] A detail survey and analysis of selectivity criteria for indole-based histone deacetylase 8 (HDAC8) inhibitors
    Moinul, Md.
    Amin, Sk. Abdul
    Khatun, Samima
    Das, Sanjib
    Jha, Tarun
    Gayen, Shovanlal
    JOURNAL OF MOLECULAR STRUCTURE, 2023, 1271
  • [2] The structural requirements of histone deacetylase inhibitors: C4-modified SAHA analogs display dual HDAC6/HDAC8 selectivity
    Negmeldin, Ahmed T.
    Knoff, Joseph R.
    Pflum, Mary Kay H.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 143 : 1790 - 1806
  • [3] A patent review of histone deacetylase 8 (HDAC8) inhibitors (2013-present)
    Banerjee, Suvankar
    Ghosh, Balaram
    Jha, Tarun
    Adhikari, Nilanjan
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2024, 34 (10) : 1019 - 1045
  • [4] A Therapeutic Perspective of HDAC8 in Different Diseases: An Overview of Selective Inhibitors
    Fontana, Anna
    Cursaro, Ilaria
    Carullo, Gabriele
    Gemma, Sandra
    Butini, Stefania
    Campiani, Giuseppe
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (17)
  • [5] Are inhibitors of histone deacetylase 8 (HDAC8) effective in hematological cancers especially acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL)?
    Amin, Sk Abdul
    Khatun, Samima
    Gayen, Shovanlal
    Das, Sanjib
    Jha, Tarun
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 258
  • [6] An efficient anticancer histone deacetylase inhibitor and its analogues for human HDAC8
    Noureen, Nighat
    Rashid, Hamid
    Kalsoom, Saima
    MEDICINAL CHEMISTRY RESEARCH, 2012, 21 (05) : 568 - 577
  • [7] Downregulation of histone deacetylase 8 (HDAC8) alleviated the progression of oral submucous fibrosis
    Yang, Hui-Wen
    Sun, Yi-Hwa
    Fang, Chih-Yuan
    Ohiro, Yoichi
    Liao, Heng-Yi
    Liao, Yi-Wen
    Kao, Yu-Hsun
    Yu, Cheng-Chia
    JOURNAL OF DENTAL SCIENCES, 2023, 18 (02) : 652 - 658
  • [8] Targeting of HDAC8 and investigational inhibitors in neuroblastoma
    Oehme, Ina
    Deubzer, Hedwig E.
    Lodrini, Marco
    Milde, Till
    Witt, Olaf
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2009, 18 (11) : 1605 - 1617
  • [9] Methionine 274 Is Not the Determining Factor for Selective Inhibition of Histone Deacetylase 8 (HDAC8) by L-Shaped Inhibitors
    Jansch, Niklas
    Lang, Kim Leoni
    Meyer-Almes, Franz-Josef
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (19)
  • [10] HDAC8 as a target in drug discovery: Function, structure and design
    Zhao, Qianlong
    Liu, Hongyan
    Peng, Jie
    Niu, Haoqian
    Liu, Jingqian
    Xue, Haoyu
    Liu, Wenjia
    Liu, Xinyu
    Hao, Huabei
    Zhang, Xinbo
    Wu, Jingde
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 280